Gene · 2823
Papers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A1BG-AS1 promotes adriamycin resistance of breast cancer by recruiting IGF2BP2 to upregulate ABCB1 in an m6A-dependent manner. | Sci Rep | 2023 | 38007504 | PubTator, text mining | PubMed |
| ALKBH5-mediated CHAC1 depletion promotes malignant progression and decreases cisplatin-induced oxidative stress in gastric cancer. | Cancer Cell Int | 2023 | 38007439 | PubTator, text mining | PubMed |
| M6A Demethylase Inhibits Osteogenesis of Dental Follicle Stem Cells via Regulating miR-7974/FKBP15 Pathway. | Int J Mol Sci | 2023 | 38003310 | PubTator, text mining | PubMed |
| The long non-coding RNA NEAT1 promotes the progression of human ovarian cancer through targeting miR-214-3p and regulating angiogenesis. | J Ovarian Res | 2023 | 37986114 | PubTator, text mining | PubMed |
| Screening of m6A gene-related lncRNAs in colon adenocarcinoma and construction of a prognostic prediction model. | Eur Rev Med Pharmacol Sci | 2023 | 37975370 | PubTator, text mining | PubMed |
| PRMT3-Mediated Arginine Methylation of METTL14 Promotes Malignant Progression and Treatment Resistance in Endometrial Carcinoma. | Adv Sci (Weinh) | 2023 | 37973560 | PubTator, text mining | PubMed |
| Profiling stress-triggered RNA condensation with photocatalytic proximity labeling. | Nat Commun | 2023 | 37968266 | PubTator, text mining | PubMed |
| Alpha Satellite DNA in Targeted Drug Therapy for Prostate Cancer. | Int J Mol Sci | 2023 | 37958565 | PubTator, text mining | PubMed |
| METTL14-m6A-FOXO3a axis regulates autophagy and inflammation in ankylosing spondylitis. | Clin Immunol | 2023 | 37935312 | PubTator, text mining | PubMed |
| Identification of M5c regulator-medicated methylation modification patterns for prognosis and immune microenvironment in glioma. | Aging (Albany NY) | 2023 | 37934565 | PubTator, text mining | PubMed |
| PPARG is a potential target of Tanshinone IIA in prostate cancer treatment: a combination study of molecular docking and dynamic simulation based on transcriptomic bioinformatics. | Eur J Med Res | 2023 | 37932808 | PubTator, text mining | PubMed |
| Epigenome-wide methylation and progression to high-grade cervical intraepithelial neoplasia (CIN2+): a prospective cohort study in the United States. | BMC Cancer | 2023 | 37932662 | PubTator, text mining | PubMed |
| Roles of USP9X in cellular functions and tumorigenesis (Review). | Oncol Lett | 2023 | 37920433 | PubTator, text mining | PubMed |
| Expression of m6A Regulator Genes can Facilitate the Diagnosis of Chronic Heart Failure. | Heart Surg Forum | 2023 | 37920080 | PubTator, text mining | PubMed |
| FTO facilitates cancer metastasis by modifying the m6A level of FAP to induce integrin/FAK signaling in non-small cell lung cancer. | Cell Commun Signal | 2023 | 37919739 | PubTator, text mining | PubMed |
| FTO plays a crucial role in gastrointestinal cancer and may be a target for immunotherapy: an updated review. | Front Oncol | 2023 | 37916161 | PubTator, text mining | PubMed |
| FTO-mediated LINC01134 stabilization to promote chemoresistance through miR-140-3p/WNT5A/WNT pathway in PDAC. | Cell Death Dis | 2023 | 37914721 | PubTator, text mining | PubMed |
| The RNA m6A-Binding Protein YTHDC1 Is Downregulated and Associated With M2 Macrophage Infiltration in Muscle-Invasive Bladder Cancer. | Clin Med Insights Oncol | 2023 | 37901254 | PubTator, text mining | PubMed |
| A Survey of Archaeal Restriction-Modification Systems. | Microorganisms | 2023 | 37894082 | PubTator, text mining | PubMed |
| N6-methyladenosine-modified oncofetal lncRNA MIR4435-2HG contributed to stemness features of hepatocellular carcinoma cells by regulating rRNA 2'-O methylation. | Cell Mol Biol Lett | 2023 | 37891494 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2823/papers?page=20